Physician profile
Vincent Zhang
NPI 1104263698
$383.33
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $36.04 · 2021: $37.55 · 2022: $83.18 · 2023: $62.59 · 2024: $164.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $227.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $226.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $93.21 | 2022-2024 | |
| Abbvie INC. | $58.08 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $43.91 | 2019-2023 | |
| Merck Sharp & Dohme LLC | $43.11 | 2023-2024 | Gardasil 9, Gardasil |
| Applied Medical Resources Corporation | $37.55 | 2021 | |
| Sumitomo Pharma America, INC. | $32.81 | 2024 | Myfembree |
| Organon LLC | $23.86 | 2024 | |
| Coopersurgical, INC. | $20.43 | 2024 | Paragard T 380a |
| Kowa Pharmaceuticals America, INC. | $16.90 | 2023 | Seglentis |
| Kci USA, INC. | $13.47 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vincent Zhang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.